
AI-powered clinical assistant for UK healthcare professionals
What investigations are recommended for a patient with chronic bronchitis to assess for COPD?
Answer
Guideline-Aligned (High Confidence)
Generated by iatroX. Developer: Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner).
Last reviewed: 14 August 2025
For a patient with chronic bronchitis, which is a symptom that can indicate chronic obstructive pulmonary disease (COPD), the diagnosis of COPD is suspected based on symptoms and signs, and supported by spirometry 1.
Key investigations recommended to assess for COPD include:
- Spirometry: Post-bronchodilator spirometry should be performed to confirm the diagnosis of COPD 1. Spirometry is performed at diagnosis, to reconsider the diagnosis for people with an exceptionally good response to treatment, and to monitor disease progression 1.
- Chest Radiograph: A chest radiograph should be obtained at the time of initial diagnostic evaluation to exclude other pathologies 1.
- Full Blood Count (FBC): An FBC should be performed to identify anaemia or polycythaemia 1.
- Body Mass Index (BMI) Calculation: BMI should be calculated as part of the initial diagnostic evaluation 1.
Additional investigations may be performed when needed, based on clinical findings:
- Sputum Culture: This is used to identify organisms if sputum is persistently present and purulent 1.
- Serial Home Peak Flow Measurements: These can be used to help exclude asthma if diagnostic doubt remains 1.
- ECG and Serum Natriuretic Peptides: These assess cardiac status if cardiac disease or pulmonary hypertension are suspected 1.
- Echocardiogram: This also assesses cardiac status if cardiac disease or pulmonary hypertension are suspected 1.
- CT Scan of the Thorax: A CT scan may be used to investigate symptoms disproportionate to spirometric impairment, signs suggesting another lung diagnosis (such as fibrosis or bronchiectasis), abnormalities on a chest X-ray, or to assess suitability for lung volume reduction procedures 1.
- Serum Alpha-1 Antitrypsin: This is assessed for alpha-1 antitrypsin deficiency if there is early onset COPD, a minimal smoking history, or a family history 1.
- Transfer Factor for Carbon Monoxide (TLCO): This investigates symptoms disproportionate to spirometric impairment or assesses suitability for lung volume reduction procedures 1.
Related Questions
Finding similar questions...